TIGIT and lung cancer: TIGIT expression has been associated with poor prognosis in non–small cell lung cancer, particularly in combination with PD-L1 expression [24], as well as in muscle-invasive bladder cancer, where it serves as a potential predictive biomarker of an inferior response to chemotherapy [22].